Condition
Merosin Deficient Congenital Muscular Dystrophy
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07125040Recruiting
Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers
NCT06924125Recruiting
Spanish Natural History Study for LAMA2 Muscular Dystrophy
NCT06354790RecruitingPrimary
Natural History Study of Children With LAMA2-related Dystrophies
NCT04299321CompletedPrimary
Retrospective Natural History Study of Infants and Toddlers With LAMA2-CMD
NCT03970135Not ApplicableCompleted
Fat and Glucose Metabolism in Fed and Fasted State in Patients With Low Skeletal Muscle Mass
Showing all 5 trials